DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)
Completed
- Conditions
- Coronary Disease
- Interventions
- Device: Multilink Vision™ Stent (CE-labeled)
- Registration Number
- NCT00243438
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation
- Detailed Description
A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1300
Inclusion Criteria
- Women and Men Age >18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent
Exclusion Criteria
- No Multi-Link Vision™ Stent implanted, life expectation >9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Multilink Vision™ Stent (CE-labeled) Patients who have received a Vision stent and who have diabetes and/or complex lesions.
- Primary Outcome Measures
Name Time Method TVF 9 months
- Secondary Outcome Measures
Name Time Method Mode of death Time to first MI TVR CABG
Trial Locations
- Locations (1)
Kerckhoff-Klinik
🇩🇪Bad Nauheim, Germany